Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Maryland Proton Treatment Center, Baltimore, Maryland University of Maryland Greenebaum Cancer Center, Baltimore, Maryland Upper Chesapeake- Kaufman Cancer Center, Bel Air, Maryland Baltimore Washington Medical Center- Tate Cancer Center, Glen Burnie, Maryland